Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Current Leases (2022 - 2025)

PAVmed has reported Current Leases over the past 4 years, most recently at $573000.0 for Q4 2025.

  • For Q4 2025, Current Leases rose 11.7% year-over-year to $573000.0; the TTM value through Dec 2025 reached $573000.0, up 11.7%, while the annual FY2025 figure was $573000.0, 11.7% up from the prior year.
  • Current Leases for Q4 2025 was $573000.0 at PAVmed, up from $557000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $1.6 million in Q3 2023 and troughed at $513000.0 in Q4 2024.
  • A 4-year average of $1.0 million and a median of $985000.0 in 2022 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: surged 53.26% in 2023 and later crashed 67.22% in 2024.
  • Year by year, Current Leases stood at $1.1 million in 2022, then skyrocketed by 37.16% to $1.6 million in 2023, then plummeted by 67.22% to $513000.0 in 2024, then increased by 11.7% to $573000.0 in 2025.
  • Business Quant data shows Current Leases for PAVM at $573000.0 in Q4 2025, $557000.0 in Q3 2025, and $542000.0 in Q2 2025.